Lithium antimony thiomalate supplier

Name
anthiolimine
EINECS
CAS No. 305-97-5
Density g/cm³
Solubility
Melting Point
Formula C4H6 O4 S . 2 Li . 1/3 Sb
Boiling Point 256.3°Cat760mmHg
Molecular Weight 604.78
Flash Point 108.8°C
Transport Information
Appearance
Safety Poison by intraperitoneal and intravenous routes. Human systemic effects by ingestion and intravenous routes: hallucinations, distorted perceptions, nausea or vomiting, skin dermatitis, and fever. An anthelmintic agent. When heated to decomposition it emits very toxic fumes of SO_x, Sb, and Li₂O. See also ANTIMONY COMPOUNDS and LITHIUM COMPOUNDS.
Risk Codes
Molecular Structure
Hazard Symbols
Synonyms Butanedioicacid, 2,2',2''-[stibylidynetris(thio)]tris-, hexalithium salt; Butanedioicacid, mercapto-, antimony(3+) lithium salt (3:1:6) (9CI); Succinic acid,mercapto-, antimonate(III), hexalithium salt (7CI); Succinic acid, mercapto-,triester with thioantimonic acid (H3SbS3), hexalithium salt (8CI);Thioantimonic acid (H3SbS3), triester with mercaptosuccinic acid, hexalithiumsalt (8CI); Anthiolimin; Anthiolimine; Anthiomaline; LAT; Lithiumantimoniothiomalate; Lithium antimony thiomalate
PSA 240.78000
LogP -9.62460

Lithium antimony thiomalate Chemical Properties

Molecular Structure of Lithium antimony thiomalate (CAS NO. 305-97-5):

IUPAC Name: Hexalithium 2-bis[(1,4-dioxido-1,4-dioxobutan-2-yl)sulfanyl]stibanylsulfanylbutanedioate
Molecular Formula: C₁₂H₉Li₆O₁₂S₃Sb
Molecular Weight: 604.793660 g/mol
H-Bond Donor: 0
H-Bond Acceptor: 12
Canonical SMILES: [Li+].[Li+].[Li+].[Li+].[Li+].[Li+].C(C(C(=O)[O-])S[Sb](SC(CC(=O)[O-])C(=O)[O-])SC(CC(=O)[O-])C(=O)[O-])C(=O)[O-]
InChI: InChI=1S/3C4H6O4S.6Li.Sb/c3*5-3(6)1-2(9)4(7)8;;;;;;;/h3*2,9H,1H2,(H,5,6)(H,7,8);;;;;;;/q;;;6*+1;+3/p-9
InChIKey: YECBTZNXNRHKJD-UHFFFAOYSA-E
Flash Point: 108.8 °C
Enthalpy of Vaporization: 54.37 kJ/mol
Boiling Point: 256.3 °C at 760 mmHg
Vapour Pressure of Lithium antimony thiomalate (CAS NO. 305-97-5): 0.00475 mmHg at 25 °C

Lithium antimony thiomalate Toxicity Data With Reference

1.	orl-hmn TDLo:11 mg/kg:GIT,MET	JAMAAP JAMA, Journal of the American Medical Association. 125 (1944),952.
2.	ivn-man TDLo:262 mg/kg/5W-I:CNS,SKN	METRA2 Medecine Tropicale (Marseille). 19 (1959),103.
3.	ipr-mus LD50:82 mg/kg	AJTMAQ American Journal of Tropical Medicine. 25 (1945),263.
4.	ivn-mus LD50:181 mg/kg	JPETAB Journal of Pharmacology and Experimental Therapeutics. 81 (1944),224.

Lithium antimony thiomalate Consensus Reports

Antimony and its compounds are on the Community Right-To-Know List.

Lithium antimony thiomalate Safety Profile

Poison by intraperitoneal and intravenous routes. Human systemic effects by ingestion and intravenous routes: hallucinations, distorted perceptions, nausea or vomiting, skin dermatitis, and fever. An anthelmintic agent. When heated to decomposition it emits very toxic fumes of SO_x, Sb, and Li₂O. See also ANTIMONY COMPOUNDS and LITHIUM COMPOUNDS.

Lithium antimony thiomalate Standards and Recommendations

OSHA PEL: TWA 0.5 mg(Sb)/m³
ACGIH TLV: TWA 0.5 mg(Sb)/m³
NIOSH REL: (Antimony) TWA 0.5 mg(Sb)/m³

Lithium antimony thiomalate Specification

Lithium antimony thiomalate with cas registry number of 305-97-5 is also known as 2,2',2"-(Stibilidynetris(thio)tris-butanedioic acid) hexalithium salt ; AI3-15246 ; Anthiolimine ; Anthioliminum ; Anthioliminum [INN-Latin] ; Anthiomaline ; Antimony lithium thiomalate ; Antiolimina ; Antiolimina [INN-Spanish] ; Anthiolimine [INN] ; Butanedioic acid, 2,2',2''-(stibylidynetris(thio))tris-, hexalithium salt ; Hexalithium 5,5',5''-stibeintriyltris(2-thiosuccinat) ; Lithium antimoniothiomalate ; Mercaptosuccinic acid S-antimony derivative lithium salt ; Mercaptosuccinic acid antimonate (III) hexalithium salt ; Mercaptosuccinic acid triester with thioantimonic acid (H₃SbS₃), hexalithium salt ; RP 110 L ; Succinic acid, mercapto-, thioantimonate(III), dilithium salt ; Stibine, tris((1,2-dicarboxyethyl)thio)-, hexalithium salt ; Tris((1,2-dicarboxyethyl)thio)stibine hexalithium salt ; UNII-TX973XBY8N .

Product Name

anthiolimine